60 Degrees Pharmaceuticals, Inc.
SXTPNASDAQHealthcare● Active
$1.43
+$0.00(+0.00%)
Market Cap$1153367
P/E Ratio—
52W High$11.84
52W Low$1.29
60 Degrees Pharmaceuticals, Inc. (SXTP) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · SXTP · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.01M | $0.61M | $0.25M | $0.22M | $1.16M |
| Cost of Revenue | $0.78M | $0.38M | $0.47M | $0.43M | $0.85M |
| Gross Profit | $0.22M | $0.22M | ($0.22M) | ($0.21M) | $0.31M |
| Gross Margin %(computed) | 22.26% | 36.67% | -87.15% | -93.71% | 26.68% |
| Operating Expenses | |||||
| R&D Expenses | $2.11M | $4.99M | $0.69M | $0.53M | $5.51M |
| G&A Expenses | $6.28M | $5.02M | $4.24M | $1.30M | $1.12M |
| Total Operating Expenses | $7.98M | $9.94M | $4.93M | $1.54M | $1.43M |
| Operating Income | ($7.76M) | ($9.71M) | ($5.15M) | ($1.75M) | ($1.12M) |
| Operating Margin %(computed) | -771.64% | — | — | -784.22% | -96.88% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.01M | $0.01M | $2.29M | $3.99M | $3.17M |
| Income Before Tax | ($7.37M) | ($7.96M) | ($3.81M) | ($6.18M) | ($4.26M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($7.37M) | ($7.95M) | ($3.77M) | ($6.18M) | ($4.25M) |
| Net Margin %(computed) | -732.82% | — | — | — | -366.42% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-11.73 | $-74.20 | $-3.80 | $-4.28 | $-2.96 |
| Wtd Avg Shares | 0.67M | 0.11M | 0.99M | 1.45M | 1.45M |
| EBITDA | ($7.28M) | ($7.88M) | ($1.43M) | ($2.11M) | ($1.01M) |
| EBITDA Margin %(computed) | -723.80% | — | -562.58% | -944.92% | -87.46% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more 60 Degrees Pharmaceuticals, Inc. data
About 60 Degrees Pharmaceuticals, Inc. (SXTP) Income Statement
60 Degrees Pharmaceuticals, Inc. (SXTP) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, SXTP reported revenue of $0.00B, gross profit of $0.00B (gross margin 22.26%), and net income of ($0.01B) — a net profit margin of -732.82%.
Frequently asked questions
SXTP · 4 questions60 Degrees Pharmaceuticals, Inc. (SXTP) reported revenue of $0.00B for 2025, up 65.5% year-over-year.
SXTP revenueSXTP salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09